New EndoVere technology can give surgeons enhanced visualization of critical structures during surgical procedures

New EndoVere technology can give surgeons enhanced visualization of critical structures during surgical procedures

PITTSBURGH, Pennsylvania,  May 10, 2019 — ChemImage is a Pittsburgh-based molecular chemical imaging company working to solve important, unmet needs in the healthcare market. In an effort to bring advanced visualization to surgery, ChemImage is developing EndoVere®, a breakthrough intraoperative endoscope technology for detection of tumor lesions and margins, key anatomic structures and tissue perfusion during common surgical procedures. Once approved, the new technology will provide a breakthrough in enhancing surgical visualization to help ensure enhanced precision and accuracy in surgical procedures globally.

 

Recently, ChemImage Clinical Researcher, Arash Samiei, MD presented a paper entitled, “Molecular Chemical Imaging Endoscope, an Innovative Imaging Modality for Enhancing the Surgeon’s View During Laparoscopic Procedures” at the 2019 American Urological Association (AUA) Annual Conference. Dr. Samiei discussed how EndoVere technology can help create “night vision type capabilities for surgeons,” enhancing their view of the surgical field and patient anatomy. The patented endoscope technology in development leverages molecular spectroscopy, digital imaging, machine learning, and computer vision to achieve real-time detections of biological materials.     

 

Dr. Samiei’s paper was well received by the AUA audience and it was recognized by evidence-based, clinical content site, UroToday.com with a feature article which can be accessed by clicking here.

 

###



Media Contact

Veronica Rillo, Marketing Manager
Office: (412) 241-7335 x269
Mobile: (801) 656-7084

Email: [email protected]

 

About ChemImage Corporation

ChemImage Corporation is a Pittsburgh based company committed to making the world healthier and safer through dramatic advancements in chemical imaging technology. The company combines proprietary, state-of-the-art imaging sensors, algorithms and analytical software to solve the world's most challenging health and safety issues.

ChemImage seeks to provide an Awareness of Things™ (AoT™) to a global audience, using the company's innovation platforms to provide people with unprecedented levels of vision, information and situational knowledge about their surroundings in their everyday lives. To accomplish this goal, the firm develops technologies for chemical and biological applications across many global industries; including life sciences, bio-medical, security, threat detection, anatomic pathology, forensics and diagnostics. 

For more information, contact ChemImage.